Literature DB >> 17303902

Risk factors, classification, and staging of renal cell cancer.

Damian A Laber1.   

Abstract

Knowledge about renal cell carcinoma (RCC) has increased exponentially over the last decades. A clear understanding of RCC is of utmost importance to prevent the disease and improve the outcomes. Large epidemiologic studies have identified cigarette smoking, chemical agents, obesity, hypertension, and end-stage renal disease as risk factors associated with RCC. Identification and confirmation of risk factors may be projected into preventive strategies. Genetic studies of inherited disorders associated with an enhanced risk of RCC have elucidated many important targets for anticancer therapy. The World Health Organization (WHO) has recently developed a new histologic classification of renal cell tumors that has demonstrated prognostic utility. A refined clinical staging system is improving our ability to prognosticate the outcome of RCC patients. This article provides a practical yet comprehensive review of the risk factors, classification, and staging of RCC focusing on recent updates.

Entities:  

Mesh:

Year:  2006        PMID: 17303902     DOI: 10.1385/MO:23:4:443

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  91 in total

1.  Renal carcinoma-associated transcription factors TFE3 and TFEB are leukemia inhibitory factor-responsive transcription activators of E-cadherin.

Authors:  Chongmin Huan; Deepa Sashital; Tiruneh Hailemariam; Matthew L Kelly; Christopher A J Roman
Journal:  J Biol Chem       Date:  2005-06-30       Impact factor: 5.157

2.  Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.

Authors:  T Cangiano; J Liao; J Naitoh; F Dorey; R Figlin; A Belldegrun
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

3.  Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.

Authors:  M de Peralta-Venturina; H Moch; M Amin; P Tamboli; S Hailemariam; M Mihatsch; J Javidan; H Stricker; J Y Ro; M B Amin
Journal:  Am J Surg Pathol       Date:  2001-03       Impact factor: 6.394

Review 4.  Molecular genetics of familial renal cell carcinoma syndromes.

Authors:  David Cohen; Ming Zhou
Journal:  Clin Lab Med       Date:  2005-06       Impact factor: 1.935

5.  Stage pT1 conventional (clear cell) renal cell carcinmoa: pathological features associated with cancer specific survival.

Authors:  J C Cheville; M L Blute; H Zincke; C M Lohse; A L Weaver
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

6.  Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.

Authors:  Ian P M Tomlinson; N Afrina Alam; Andrew J Rowan; Ella Barclay; Emma E M Jaeger; David Kelsell; Irene Leigh; Patricia Gorman; Hanan Lamlum; Shamima Rahman; Rebecca R Roylance; Simon Olpin; Stephen Bevan; Karen Barker; Nicholas Hearle; Richard S Houlston; Maija Kiuru; Rainer Lehtonen; Auli Karhu; Susa Vilkki; Päivi Laiho; Carita Eklund; Outi Vierimaa; Kristiina Aittomäki; Marja Hietala; Pertti Sistonen; Anders Paetau; Reijo Salovaara; Riitta Herva; Virpi Launonen; Lauri A Aaltonen
Journal:  Nat Genet       Date:  2002-02-25       Impact factor: 38.330

7.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 8.  Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

Authors:  W Marston Linehan; James Vasselli; Ramaprasad Srinivasan; McClellan M Walther; Maria Merino; Peter Choyke; Cathy Vocke; Laura Schmidt; Jennifer S Isaacs; Gladys Glenn; Jorge Toro; Berton Zbar; Donald Bottaro; Len Neckers
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

9.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

10.  Renal medullary carcinoma. The seventh sickle cell nephropathy.

Authors:  C J Davis; F K Mostofi; I A Sesterhenn
Journal:  Am J Surg Pathol       Date:  1995-01       Impact factor: 6.394

View more
  7 in total

Review 1.  Radiofrequency ablation of renal tumors.

Authors:  Michael J Stone; Aradhana M Venkatesan; Julia Locklin; Peter Pinto; Marston Linehan; Bradford J Wood
Journal:  Tech Vasc Interv Radiol       Date:  2007-06

2.  Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma.

Authors:  Katherine A Murphy; Britnie R James; Yue Guan; Donald S Torry; Andrew Wilber; Thomas S Griffith
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Cutting Edge: Elevated Leptin during Diet-Induced Obesity Reduces the Efficacy of Tumor Immunotherapy.

Authors:  Katherine A Murphy; Britnie R James; Frances V Sjaastad; Tamara A Kucaba; Hyunjoon Kim; Erik L Brincks; Streamson C Chua; Andrew Wilber; Thomas S Griffith
Journal:  J Immunol       Date:  2018-08-22       Impact factor: 5.422

4.  CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.

Authors:  Britnie R James; Kristin G Anderson; Erik L Brincks; Tamara A Kucaba; Lyse A Norian; David Masopust; Thomas S Griffith
Journal:  Cancer Immunol Immunother       Date:  2014-08-21       Impact factor: 6.968

Review 5.  Basic research in kidney cancer.

Authors:  Egbert Oosterwijk; W Kimryn Rathmell; Kerstin Junker; A Rose Brannon; Frédéric Pouliot; David S Finley; Peter F A Mulders; Ziya Kirkali; Hirotsugo Uemura; Arie Belldegrun
Journal:  Eur Urol       Date:  2011-07-05       Impact factor: 20.096

6.  Cigarette smoking among school-going adolescents in Kafue, Zambia.

Authors:  Seter Siziya; Emmanuel Rudatsikira; Adamson S Muula
Journal:  Malawi Med J       Date:  2007-06       Impact factor: 0.875

7.  Renal tumors and second primary pancreatic tumors: a relationship with clinical impact?

Authors:  Sascha A Müller; Sascha Pahernik; Ulf Hinz; David J Martin; Moritz N Wente; Thilo Hackert; Christine Leowardi; Axel Haferkamp; Markus W Büchler; Bruno M Schmied
Journal:  Patient Saf Surg       Date:  2012-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.